Literature DB >> 19282666

A new take on ceramide: starving cells by cutting off the nutrient supply.

Garret G Guenther1, Aimee L Edinger.   

Abstract

Ceramide generation is increased by a broad array of signals. In general, ceramide limits cell survival and proliferation and promotes differentiation and senescence. Despite its role in the pathogenesis of multiple human diseases, ceramide's mechanism of action remains poorly defined. Understanding how this sphingolipid modulates cell physiology is therefore an important goal. Building on prior observations that ceramide induces autophagy, we demonstrate that ceramide kills cells by inducing severe bioenergetic stress secondary to nutrient transporter downregulation. In support of this model, maintaining nutrient access blocks ceramide-induced autophagy and cell death. This bioenergetic mechanism of action may explain the increased sensitivity of cancer cells to ceramide. Starvation induces quiescence in normal cells. Tumor cells, in contrast, carry oncogenic mutations that block the switch to catabolism and prevent a reduction in metabolic demand leading to a bioenergetic crisis when nutrients become scarce. We propose that the non-lethal effects of ceramide might also stem from ceramide-induced starvation. While severe nutrient stress kills cells, mild nutrient limitation slows proliferation and may contribute to the induction of senescence. In sum, our new model for ceramide action suggests that regulated nutrient transporter expression may play a previously unappreciated role in cancer and other diseases where ceramide metabolism is altered.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19282666     DOI: 10.4161/cc.8.8.8161

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  14 in total

Review 1.  Sphingolipids and lifespan regulation.

Authors:  Xinhe Huang; Bradley R Withers; Robert C Dickson
Journal:  Biochim Biophys Acta       Date:  2013-08-15

Review 2.  Ceramide induced mitophagy and tumor suppression.

Authors:  Mohammed Dany; Besim Ogretmen
Journal:  Biochim Biophys Acta       Date:  2015-01-26

Review 3.  Autophagy paradox and ceramide.

Authors:  Wenhui Jiang; Besim Ogretmen
Journal:  Biochim Biophys Acta       Date:  2013-09-19

Review 4.  Sphingolipids, lipotoxic cardiomyopathy, and cardiac failure.

Authors:  Tae-Sik Park; Ira J Goldberg
Journal:  Heart Fail Clin       Date:  2012-08-10       Impact factor: 3.179

Review 5.  Ceramides as modulators of cellular and whole-body metabolism.

Authors:  Benjamin T Bikman; Scott A Summers
Journal:  J Clin Invest       Date:  2011-11-01       Impact factor: 14.808

Review 6.  Roles of the Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR pathways in controlling growth and sensitivity to therapy-implications for cancer and aging.

Authors:  Linda S Steelman; William H Chappell; Stephen L Abrams; Ruth C Kempf; Jacquelyn Long; Piotr Laidler; Sanja Mijatovic; Danijela Maksimovic-Ivanic; Franca Stivala; Maria C Mazzarino; Marco Donia; Paolo Fagone; Graziella Malaponte; Ferdinando Nicoletti; Massimo Libra; Michele Milella; Agostino Tafuri; Antonio Bonati; Jörg Bäsecke; Lucio Cocco; Camilla Evangelisti; Alberto M Martelli; Giuseppe Montalto; Melchiorre Cervello; James A McCubrey
Journal:  Aging (Albany NY)       Date:  2011-03       Impact factor: 5.682

Review 7.  Attacking the supply wagons to starve cancer cells to death.

Authors:  Elizabeth M Selwan; Brendan T Finicle; Seong M Kim; Aimee L Edinger
Journal:  FEBS Lett       Date:  2016-03-22       Impact factor: 4.124

8.  TNF-α- and tumor-induced skeletal muscle atrophy involves sphingolipid metabolism.

Authors:  Joffrey De Larichaudy; Alessandra Zufferli; Filippo Serra; Andrea M Isidori; Fabio Naro; Kevin Dessalle; Marine Desgeorges; Monique Piraud; David Cheillan; Hubert Vidal; Etienne Lefai; Georges Némoz
Journal:  Skelet Muscle       Date:  2012-01-18       Impact factor: 4.912

9.  Down-regulating sphingolipid synthesis increases yeast lifespan.

Authors:  Xinhe Huang; Jun Liu; Robert C Dickson
Journal:  PLoS Genet       Date:  2012-02-02       Impact factor: 5.917

Review 10.  Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR inhibitors: rationale and importance to inhibiting these pathways in human health.

Authors:  William H Chappell; Linda S Steelman; Jacquelyn M Long; Ruth C Kempf; Stephen L Abrams; Richard A Franklin; Jörg Bäsecke; Franca Stivala; Marco Donia; Paolo Fagone; Graziella Malaponte; Maria C Mazzarino; Ferdinando Nicoletti; Massimo Libra; Danijela Maksimovic-Ivanic; Sanja Mijatovic; Giuseppe Montalto; Melchiorre Cervello; Piotr Laidler; Michele Milella; Agostino Tafuri; Antonio Bonati; Camilla Evangelisti; Lucio Cocco; Alberto M Martelli; James A McCubrey
Journal:  Oncotarget       Date:  2011-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.